Rybelsus is an oral formulation of semaglutide available in 3 mg, 7 mg, and 14 mg tablets, representing a fundamentally different delivery system with distinct pharmacokinetics and dosing protocols
Studies have documented maintained IGF-1 elevation for up to 2 weeks following a single CJC-1295 administration in some protocols
For sponsors developing non-GLP-1 peptide programmes in oncology, rare disease, or other therapeutic areas, the competition for the same SPPS reactor capacity, the same HPLC purification infrastructure, and the same analytical characterisation capability has materially lengthened lead times and elevated costs
Other mechanisms that sustain AR action under ADT include expression of AR from ecDNAs or induction of the structurally related nuclear receptor glucocorticoid receptor (GR) that can take over control over at least a fraction of the AR-dependent cistrome and transcriptome [37,38,39]